Patents Assigned to Satori Pharmaceuticals, Inc.
  • SYNTHESIS OF COMPOUNDS USEFUL AS MODULATORS OF AMYLOID-BETA PRODUCTION
    Publication number: 20130059804
    Abstract: As described herein, the present invention provides methods for preparing compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    Type: Application
    Filed: August 3, 2012
    Publication date: March 7, 2013
    Applicant: SATORI PHARMACEUTICALS, INC.
    Inventor: Mark A. Findeis
  • Compounds useful for treating neurodegenerative disorders
    Publication number: 20130060022
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein R1 and R5 are as defined and described herein, compositions thereof, and methods of using the same.
    Type: Application
    Filed: September 6, 2012
    Publication date: March 7, 2013
    Applicant: Satori Pharmaceuticals, Inc.
    Inventors: Brian Scott Bronk, Wesley Francis Austin, Steffen Phillip Creaser, Nathan Oliver Fuller, Jed Lee Hubbs, Jeffrey Lee Ives, Ruichao Shen
  • Compounds for Use in Treating Neurodegenerative Disorders, Synthesis Thereof, and Intermediates Thereto
    Publication number: 20130060019
    Abstract: The present invention provides methods of making a compound of formula II: or a pharmaceutically acceptable salt thereof, wherein R1, R2, and L are as defined and described herein.
    Type: Application
    Filed: September 6, 2012
    Publication date: March 7, 2013
    Applicant: SATORI PHARMACEUTICALS, INC.
    Inventors: Brian Scott Bronk, Wesley Francis Austin, Steffen Phillip Creaser, Nathan Oliver Fuller, Jed Lee Hubbs, Ruichao Shen
  • Compounds useful for treating neurodegenerative disorders
    Publication number: 20130060021
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein L and Ring A are as defined and described herein, compositions thereof, and methods of using the same.
    Type: Application
    Filed: September 6, 2012
    Publication date: March 7, 2013
    Applicant: Satori Pharmaceuticals, Inc.
    Inventors: Brian Scott Bronk, Wesley Francis Austin, Steffen Phillip Creaser, Nathan Oliver Fuller, Jed Lee Hubbs, Jeffrey Lee Ives, Ruichao Shen
  • Compounds useful for treating neurodegenerative disorders
    Publication number: 20130060013
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein each of the variables listed above are as defined and described herein, compositions thereof, and methods of using the same.
    Type: Application
    Filed: September 6, 2012
    Publication date: March 7, 2013
    Applicant: SATORI PHARMACEUTICALS, INC.
    Inventors: Brian Scott Bronk, Wesley Francis Austin, Steffen Phillip Creaser, Nathan Oliver Fuller, Jed Lee Hubbs, Jeffrey Lee Ives, Ruichao Shen
  • Compounds useful for treating neurodegenerative disorders
    Publication number: 20130060023
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein Rx is as defined and described herein, compositions thereof, and methods of using the same.
    Type: Application
    Filed: September 6, 2012
    Publication date: March 7, 2013
    Applicant: Satori Pharmaceuticals, Inc.
    Inventors: Brian Scott Bronk, Wesley Francis Austin, Steffen Phillip Creaser, Nathan Oliver Fuller, Jed Lee Hubbs, Jeffrey Lee Ives, Ruichao Shen
  • Compounds useful for treating neurodegenerative disorders
    Publication number: 20130060024
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein R1 is as defined and described herein, compositions thereof, and methods of using the same.
    Type: Application
    Filed: September 6, 2012
    Publication date: March 7, 2013
    Applicant: SATORI PHARMACEUTICALS, INC.
    Inventors: Brian Scott Bronk, Wesley Francis Austin, Steffen Phillip Creaser, Nathan Oliver Fuller, Jed Lee Hubbs, Jeffrey Lee Ives, Ruichao Shen
  • Compounds useful for treating neurodegenerative disorders
    Publication number: 20130060020
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein Rx is as defined and described herein, compositions thereof, and methods of using the same.
    Type: Application
    Filed: September 6, 2012
    Publication date: March 7, 2013
    Applicant: Satori Pharmaceuticals, Inc.
    Inventors: Brian Scott Bronk, Wesley Francis Austin, Steffen Phillip Creaser, Nathan Oliver Fuller, Jed Lee Hubbs, Jeffrey Lee Ives, Ruichao Shen
  • MODULATORS OF AMYLOID-BETA PRODUCTION
    Publication number: 20120283217
    Abstract: As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    Type: Application
    Filed: July 16, 2012
    Publication date: November 8, 2012
    Applicant: SATORI PHARMACEUTICALS, INC.
    Inventors: Mark A. Findeis, Steffen P. Creaser
  • Synthesis of compounds useful as modulators of amyloid-beta production
    Patent number: 8263755
    Abstract: As described herein, the present invention provides methods for preparing compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    Type: Grant
    Filed: November 20, 2007
    Date of Patent: September 11, 2012
    Assignee: Satori Pharmaceuticals, Inc.
    Inventor: Mark A. Findeis
  • COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20110251379
    Abstract: As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    Type: Application
    Filed: March 3, 2011
    Publication date: October 13, 2011
    Applicant: Satori Pharmaceuticals, Inc.
    Inventors: Brian Scott Bronk, Wesley Francis Austin, Steffen Phillip Creaser, Mark A. Findeis, Nathan Oliver Fuller, Jed Lee Hubbs, Jeffrey Lee Ives, Ruichao Shen
  • COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20110136749
    Abstract: As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    Type: Application
    Filed: December 1, 2010
    Publication date: June 9, 2011
    Applicant: SATORI PHARMACEUTICALS, INC.
    Inventors: Mark A. Findeis, Kollol Pal, Frank Schroeder
  • COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20110136750
    Abstract: As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    Type: Application
    Filed: December 1, 2010
    Publication date: June 9, 2011
    Applicant: SATORI PHARMACEUTICALS, INC.
    Inventors: Mark A. Findeis, Kollol Pal, Frank Schroeder
  • Compounds useful for treating neurodegenerative disorders
    Patent number: 7851641
    Abstract: As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    Type: Grant
    Filed: May 16, 2006
    Date of Patent: December 14, 2010
    Assignee: Satori Pharmaceuticals, Inc.
    Inventors: Mark A. Findeis, Kollol Pal, Frank Schroeder
  • SYNTHESIS OF COMPOUNDS USEFUL AS MODULATORS OF AMYLOID-BETA PRODUCTION
    Publication number: 20100197615
    Abstract: As described herein, the present invention provides methods for preparing compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    Type: Application
    Filed: November 20, 2007
    Publication date: August 5, 2010
    Applicant: SATORI PHARMACEUTICALS, INC.
    Inventor: Mark Findeis
  • COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20100144689
    Abstract: As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    Type: Application
    Filed: December 17, 2009
    Publication date: June 10, 2010
    Applicant: Satori Pharmaceuticals, Inc.
    Inventor: Mark A. FINDEIS
  • MODULATORS OF AMYLOID-BETA PRODUCTION
    Publication number: 20100056487
    Abstract: As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    Type: Application
    Filed: November 20, 2007
    Publication date: March 4, 2010
    Applicant: Satori Pharmaceuticals, Inc.
    Inventors: Mark A. Findeis, Steffen P. Creaser